These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 221426)

  • 41. Serological evidence of hepatitis B infection in patients with chronic liver diseases: radioimmunoassay of HBsAg and anti-HBs.
    Skinhöj P; Nielsen JO; Dietrichson O
    Scand J Gastroenterol; 1977; 12(5):615-9. PubMed ID: 918556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distribution of HBs antigen in livers revealed by orcein staining.
    Nakaso S; Sakurai M
    Hepatogastroenterology; 1982 Feb; 29(1):9-12. PubMed ID: 6178673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey.
    Hislop WS; Follett EA; Bouchier IA; MacSween RN
    J Clin Pathol; 1981 Sep; 34(9):1017-9. PubMed ID: 7276216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
    Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
    J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. e System and intrahepatocelullar HBcAG and HBsAG in HBsAG positive patients with liver diseases and healthy carriers.
    Hess G; Nielsen JO; Arnold W; Büschenfelde KH
    Scand J Gastroenterol; 1977; 12(3):325-30. PubMed ID: 866995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis-B virus determinant in patients with liver disease in Malawi.
    Molyneux ME; Supran EM; Islam MN; Banatvala JE; Hutt MS
    Trans R Soc Trop Med Hyg; 1980; 74(3):383-8. PubMed ID: 6254218
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on circulating immune complexes of the liver diseases. 5. Anti-DNA antibodies and C1q binding activity.
    Arima T; Narumoto J; Shimomura H; Yasuhara T; Kunishi K; Suwaki K; Nagashima H
    Gastroenterol Jpn; 1980 Apr; 15(2):167-172. PubMed ID: 7380168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Determination of theAustralia-SH-antigen in liver diseases].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Uhlig K; Geserick G; Müller G
    Dtsch Gesundheitsw; 1970 Sep; 25(39):1830-1. PubMed ID: 5485818
    [No Abstract]   [Full Text] [Related]  

  • 51. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study.
    Kwon OS; Jung YK; Bae KS; Kim JH; Kim SG; Kim YS; Lee JI; Lee JW; Kim YS
    Alcohol; 2012 Sep; 46(6):537-41. PubMed ID: 22572059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Circulating immune complexes in patients with acute and chronic diseases of the liver].
    Uibo RM; Nutt HR; Prjukk TJ
    Ter Arkh; 1989; 61(2):61-4. PubMed ID: 2524905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C virus antibodies in patients with liver disease. The western Cape experience.
    Robson SC; du Toit JM; Brice EA; Bird AR; Brink NS
    S Afr Med J; 1991 Sep; 80(6):282-4. PubMed ID: 1656534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis-associated antigen in chronic liver disease.
    Fox RA; Niazi SP; Sherlock S
    Lancet; 1969 Sep; 2(7621):609-12. PubMed ID: 4185591
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hepatitis B virus antigens in liver resections from patients with hepatocellular carcinoma].
    Decker T; Ruhnke M
    Zentralbl Allg Pathol; 1988; 134(2):197-205. PubMed ID: 2844035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B surface antigen in hepatocytes at necropsy.
    Ho JC; Wu PC; Gibson JB
    Arch Pathol Lab Med; 1980 May; 104(5):255-7. PubMed ID: 6245627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
    Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
    Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
    Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
    Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatitis and Australia antigen--with special reference to clinical problems].
    Ichida F
    Nihon Rinsho; 1971; 29(4):1201-7. PubMed ID: 4931317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.